Warning: Trying to access array offset on value of type bool in /var/www/vhosts/oncodaily.com/public_html/pub/themes/oncodailynews/single.php on line 25
Warning: Trying to access array offset on value of type bool in /var/www/vhosts/oncodaily.com/public_html/pub/themes/oncodailynews/single.php on line 26
Apr 2, 2024, 05:10
Chul Kim: March has been fruitful and rewarding, as we launched two IITs of ADC back to back!
Chul Kim, Thoracic Medical Oncologist at Georgetown University, shared on X/Twitter:
“March has been fruitful and rewarding, as we launched two IITs of ADC back to back!
1. Vobramitamab duocarmazine (B7-H3 ADC) for ES-SCLC, inclusive of patients with transformed SCLC (NCT06227546),
2. Sacituzumab govitecan for thymic epithelial tumors (NCT06248515).”
Source: Chul Kim/X